Back to User profile » Dr Haya Ascher-Svanum
Papers published by Dr Haya Ascher-Svanum:
Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?
Montgomery W, Treuer T, Ye W, Xue HB, Wu SH, Liu L, Kadziola Z, Stensland MD, Ascher-Svanum H
Neuropsychiatric Disease and Treatment 2014, 10:1287-1296
Published Date: 10 July 2014
Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection
Ascher-Svanum H, Novick D, Haro JM, Bertsch J, McDonnell D, Detke H
Neuropsychiatric Disease and Treatment 2014, 10:1125-1131
Published Date: 20 June 2014
Movement disorder profile and treatment outcomes in a one-year study of patients with schizophrenia
Chen L, Ascher-Svanum H, Lawson A, Stauffer VL, Nyhuis A, Haynes V, Schuh K, Kinon BJ
Neuropsychiatric Disease and Treatment 2013, 9:815-822
Published Date: 14 June 2013
Validation of a patient interview for assessing reasons for antipsychotic discontinuation and continuation
Matza LS, Phillips GA, Revicki DA, Ascher-Svanum H, Malley KG, Palsgrove AC, Faries DE, Stauffer V, Kinon BJ, Awad AG, Keefe RS, Naber D
Patient Preference and Adherence 2012, 6:521-532
Published Date: 13 July 2012
Reasons for continuing or discontinuing olanzapine in the treatment of schizophrenia from the perspectives of patients and clinicians
Chen J, Ascher-Svanum H, Nyhuis AW, Case MG, Phillips GA, Schuh KJ, Hoffmann VP
Patient Preference and Adherence 2011, 5:547-554
Published Date: 3 November 2011